Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma | MicrobiomeTrials← Back to trialsNCT07218315
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-02-11Est. Completion: 2029-01-31
Enrollment target: 15 participants Locations- Sarasota Memorial Hospital, Sarasota, Florida, United States
- The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
MelanomaGliomaThyroid CancerNon-Small Cell Lung CancerMalignant NeoplasmsBrain NeoplasmsAdvanced or Metastatic Solid TumorsHGGLGGLow Grade GliomaHigh Grade GliomaDifferentiated Thyroid CancerNSCLC (Non-small Cell Lung Cancer)
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in co…
Birmingham, United StatesEst. completion Aug 2, 2027
Background:
Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare disease with few treatment options. Researchers are…
Bethesda, United StatesEst. completion Jul 1, 2032
Papillary Thyroid Microcarcinoma
Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefull…
Budapest, HungaryCompleted Dec 31, 2025